Diabetic Retenopathy Management - A Case Study

Gouri Sakre
{"title":"Diabetic Retenopathy Management - A Case Study","authors":"Gouri Sakre","doi":"10.47363/jorrr/2021(2)113","DOIUrl":null,"url":null,"abstract":"Diabetic retinopathy is a complication of diabetes, caused by high blood sugar levels damaging Retina. It usually takes several years for diabetic retinopathy to reach a stage where it could threaten the sight, if left undiagnosed and untreated. Starting with only a mild vision problem, retinopathy usually appears five years after a type 1 diabetes diagnosis. But it may already be present when type 2 diabetes is diagnosed. We present one such case in a lady of 38 years old, tailor by profession, diagnosed as Type 2 diabetes since 2019, suspected to have had proliferative diabetic retinopathy in January 2020, reported at a Medical College Hospital on 15th December 2020 with periorbital headache for fifteen days. Fundal examination revealed hard exudates and Neo vascularization in both eyes. She was advised Photocoagulation but after her blood sugar was controlled. In the meantime, she was advised to use Nepafenac eye suspension four times daily for pain and redness of the right eye. Investigations had revealed her RBS was 392mg/dl, for which a general physician (internal medicine) was consulted who put her Tab. Metformin 500mg 1-1-1 B/F, Tab. Teneligliptin 20mg 0-1-0 A/F. Unfortunately, 2 months of follow up and diabetes management did not allow her to be taken up for photocoagulation. The institution was firm on their decision to plan her laser photocoagulation for both eyes only when the blood sugar levels come to a range of 140 to 160mg/dl. On 26th March 2021, she was rushed to the Medical College hospital as she complained of loss of vision in the Right eye. The fundus examination revealed multiple dot and blot hemorrhages in both eyes, bleed in oculus dexter and oculus sinister, hard exudates in the right eye that needed Vitreoretinal surgery. Since the Medical College Hospital did not have the Vitreoretinal surgery facility, she was taken to a private dedicated eye hospital, where she underwent laser photocoagulation of left eye on 12/04/21 followed by Vitrectomy of right eye for proliferative diabetic retinopathy on 24th April 2021. There were no postoperative hemorrhages until three days or any other complications after surgery. Now she can recognize some shapes with her right eye by closing left eye.","PeriodicalId":373984,"journal":{"name":"Journal of Ophthalmology Research Reviews & Reports","volume":"424 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmology Research Reviews & Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jorrr/2021(2)113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Diabetic retinopathy is a complication of diabetes, caused by high blood sugar levels damaging Retina. It usually takes several years for diabetic retinopathy to reach a stage where it could threaten the sight, if left undiagnosed and untreated. Starting with only a mild vision problem, retinopathy usually appears five years after a type 1 diabetes diagnosis. But it may already be present when type 2 diabetes is diagnosed. We present one such case in a lady of 38 years old, tailor by profession, diagnosed as Type 2 diabetes since 2019, suspected to have had proliferative diabetic retinopathy in January 2020, reported at a Medical College Hospital on 15th December 2020 with periorbital headache for fifteen days. Fundal examination revealed hard exudates and Neo vascularization in both eyes. She was advised Photocoagulation but after her blood sugar was controlled. In the meantime, she was advised to use Nepafenac eye suspension four times daily for pain and redness of the right eye. Investigations had revealed her RBS was 392mg/dl, for which a general physician (internal medicine) was consulted who put her Tab. Metformin 500mg 1-1-1 B/F, Tab. Teneligliptin 20mg 0-1-0 A/F. Unfortunately, 2 months of follow up and diabetes management did not allow her to be taken up for photocoagulation. The institution was firm on their decision to plan her laser photocoagulation for both eyes only when the blood sugar levels come to a range of 140 to 160mg/dl. On 26th March 2021, she was rushed to the Medical College hospital as she complained of loss of vision in the Right eye. The fundus examination revealed multiple dot and blot hemorrhages in both eyes, bleed in oculus dexter and oculus sinister, hard exudates in the right eye that needed Vitreoretinal surgery. Since the Medical College Hospital did not have the Vitreoretinal surgery facility, she was taken to a private dedicated eye hospital, where she underwent laser photocoagulation of left eye on 12/04/21 followed by Vitrectomy of right eye for proliferative diabetic retinopathy on 24th April 2021. There were no postoperative hemorrhages until three days or any other complications after surgery. Now she can recognize some shapes with her right eye by closing left eye.
糖尿病视网膜病变管理-个案研究
糖尿病视网膜病变是糖尿病的一种并发症,由高血糖水平损害视网膜引起。如果不及时诊断和治疗,糖尿病视网膜病变通常需要几年的时间才能发展到可能威胁视力的阶段。一开始只有轻微的视力问题,视网膜病变通常在1型糖尿病诊断5年后出现。但在诊断出2型糖尿病时,它可能已经存在了。我们报告了一例此类病例,患者为一名38岁的女性,职业为裁缝,自2019年以来被诊断为2型糖尿病,2020年1月疑似患有增生性糖尿病视网膜病变,于2020年12月15日在一所医学院医院报告,眼眶周围头痛15天。眼底检查显示双眼有硬渗出及新生血管形成。医生建议她进行光凝治疗,但在她的血糖得到控制后。同时,因右眼疼痛、红肿,建议每日4次使用neafenac眼液。调查显示,她的RBS是392毫克/分升,为此咨询了一位普通医生(内科),他给她开了Tab。二甲双胍500mg 1-1-1 B/F,标签。替尼格列汀20mg 0-1-0 A/F。不幸的是,2个月的随访和糖尿病治疗不允许她进行光凝治疗。该机构坚持他们的决定,只有当她的血糖水平达到140到160毫克/分升的范围时,他们才计划对她的双眼进行激光光凝治疗。2021年3月26日,她因抱怨右眼视力丧失而被紧急送往医学院医院。眼底检查发现双眼多发点、点出血,右眼右、右眼出血,右眼硬渗出,需行玻璃体视网膜手术。由于医学院医院没有玻璃体视网膜手术设施,她被送往一家私人眼科医院,在那里她于21年4月12日对左眼进行了激光光凝治疗,随后于2021年4月24日对右眼进行了玻璃体切除术,以治疗增生性糖尿病视网膜病变。术后3天无出血,术后无其他并发症。现在她可以闭上左眼,用右眼识别一些形状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信